Physician profile
Nathan P Reed
NPI 1306066634
$873.63
in general payments reported to CMS, 2019-2025
11 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2021: $15.26 · 2022: $124 · 2023: $137 · 2024: $157 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604 · Entertainment: $28.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.24 |
| Entertainment | $28.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $300.79 | 2019-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Medtronic, INC. | $119.64 | 2025 | Signia |
| Aroa Biosurgery Incorporated | $101.87 | 2022 | |
| Abbvie INC. | $88.27 | 2024-2025 | |
| Integra Lifesciences Corporation | $86.09 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Omeros Corporation | $58.55 | 2019-2021 | |
| Optos, INC. | $28.47 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Rayner Intraocular Lenses Limited | $27.39 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Novartis Pharmaceuticals Corporation | $25.29 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $23.14 | 2023 | Catalys System |
| Bausch & Lomb Americas INC. | $14.13 | 2025 | Xiidra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.